The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 27 March 2007, www.theannals.com, DOI 10.1345/aph.1K051.
 The Annals of Pharmacotherapy: Vol. 41, No. 4, pp. 690-692. DOI 10.1345/aph.1K051
© 2007 Harvey Whitney Books Company.
This Article
Right arrow Abstract Freely available
Right arrow Résumé Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in The Annals
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drew, R. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drew, R. H

La cambiante epidemiología de la candidiasis invasora, junto con la preocupación por aumentos en la resistencia a medicamentos, han requerido que pacientes a alto riesgo a desarrollar Cándida no-albicans sean identificados para así optimizar la selección del tratamiento antifúngico. Se discuten los resultados principales de un estudio con respecto a las características demográficas, los costos, y resultados de pacientes no-neutropénicos con candidemia debido a Cándida no-albicans. Dadas las opciones disponibles para tratamiento, tal valoración de riesgo es la más relevante al inicio de la terapia empírica en pacientes estables sin neutropenia que podrían ser candidatos a la terapia inicial con un agente azólico (tal como fluconazol). Los autores del estudio apoyan el requerimiento de terapia antifúngica oportuna para los pacientes con candidemia.

Carlos C da Camara

www.theannals.com, DOI 10.1345/aph.1K051

Related articles in The Annals:

Epidemiology, Risk Factors, and Outcomes of Candida albicans Versus Non-albicans Candidemia in Nonneutropenic Patients
Susan L Davis, Jose A Vazquez, and Peggy S McKinnon
The Annals 2007 41: 568-573. [Abstract] [Full Text]  




This Article
Right arrow Abstract Freely available
Right arrow Résumé Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in The Annals
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drew, R. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drew, R. H

homecopy help contact us subscription past issues search current issue
Copyright © 2007 by Harvey Whitney Books Company.